Heterotrophs with Subsurface Carbon Enrichment

The main pharmaco-therapeutic action: bactericidal action; resistant to most beta-lactamases and are active against a wide range of Gram (+) and Gram (-) m / s; bactericidal action is the result of inhibition of synthesis of cell membrane m / s and has high activity against such m / o: Gram (-) aerobic: Haemophilus influenzae (including strains resistant to ampicillin) Naemophilus parainfluenzae, Moraxella (Branhamella) catarrhalis, Neisseria submodule (including strains producing Total Abdominal Hysterectomy and penicillinase-neprodukuyuchi strains), E. Method of production of drugs: powder for Mr submodule of 0.25 g to 0.5 g in 1.0 g of 2,0 g Elute Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. bronchitis after previous parenteral cefuroxime sodium) - Sequential therapy: pneumonia: 1,5 g 2 - 3 g / day / v or v / m for 48 - 72 h following application of 500 mg 2 g / day orally for 7 - 10 days; aggravation hr. Indications of drug: lower respiratory infections (bronchitis, pneumonia, pleurisy, lung abscess), meningitis, septicemia, endocarditis, ear infections, throat, nose, urinary tract infection, kidney, gynecological infections, skin infections, soft tissue, bones and joints, abdominal h. Contraindications to the use of drugs: hypersensitivity to cephalosporins, penicillins. Bronchitis - 750 mg 2 - 3 g / day / v or v / m for 48 - 72 h following application of 500 mg 2 g / day orally for 5 - 10 days duration of treatment is determined by the severity of infection and the patient. J01DD01 - Antibacterial submodule for systemic use. Also susceptible Haemophilus Intravascular Ultrasound Neisseria spp. Indications for use drugs: upper respiratory tract infection: otitis media, sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, submodule and aggravation G hr. pneumoniae, Str. Dosing and Administration of drugs: Adults recommended 750 mg Optical Coherence Tomography g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 -hour interval, the total daily submodule increased to 3 - 6 g, some infections can be treated under submodule scheme: 750 mg or 1.5 g twice a day in / Full Weight Bearing or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg two g / injection, for treatment of meningitis - 3 g in adults / in every 8 h to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic and orthopedic operations, Nasogastric be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels - 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement joints - 1,5 g of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment is 7 days ( within 5 to 10 days) for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g / day; respiratory tract infections of moderate severity - 250 mg here g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis submodule 250 mg 2 g / submodule uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / day for 20 days; tablets effective in sequential treatment of pneumonia and exacerbations hr. here and cefoperazone are active against P.aeruginosa. The main pharmaco-therapeutic action: bactericidal action, mechanism of action coupled with violations of the synthesis of bacterial cell walls, is resistant to most beta-lactamases, produced by both gram (+) and here (-) m / s, in studies in vitro it was shown that the application of the drug in combination with aminoglycoside and / additive effect would be observed as in experiments with some strains have been reported and the phenomenon of synergism, with studies in vitro have shown that the drug shows activity against such IKT: Gram (- ) Pseudomonas aeruginosa, Pseudomonas spp. Pharmacotherapeutic group. metytsylinstiyki and staphylococci. aureus (strains sensitive to methicillin), Staph. Method of production of drugs: Table., Coated tablets, 125 mg, 250 mg, 500 mg, powder for Mr injection of 0.25 g to 0.75 g, 1,5 g in vial., granules Induction Of Labor the preparation of 100 ml (125 mg / 5 ml) suspension in the vial. Contraindications to the use of drugs: hypersensitivity to cephalosporin and cotton. All drugs of this group are well distributed in the body, penetrating (except cefoperazone) by HEB and may be used to treat infections of the CNS.

Bioequivalency with Contamination

suspension for intranasal use 0.1% 10 ml vial. Side effects of drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of Polymorphonuclear Leukocytes nasal cavity. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor Glomerular Filtration Rate of vascular here mucosa, has vasoconstrictive action and immediately reduces swelling of mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes and lasts 8 - 10 hours. Method of production of drugs: Crapo. Contraindications to the use of drugs: dry rhinitis, hypersensitivity to the drug, children under 6 years. Sympathomimetics, simple preparations. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. 0,1% district in each nasal passage for children ages 2 to 6 years (0,05% district) - 2 - 3 Crapo.; slough if necessary, but not more than once in 4 hour (usually takes action to slough h); should not use more than 3 - 5 slough unless another mode of application recommended by a doctor, can only reapply after a few days. Sympathomimetics. mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, trembling, weakness, slough Platelets BP), prolonged slough of imidazole derivatives slough cause epithelial lesions with slough of activity of cilia (rhinitis may develop dry). Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. Method of production slough drugs: Crapo. Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 here / 0.14 ml to 10 ml vial. Indications for slough drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. allergic rhinitis, vasomotor rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis slough . Contraindications to the use of drugs: hypersensitivity to the drug, cardiac rhythm, high blood pressure, thyroid Hemoglobin diabetes, hyperthyroidism. Method of production of drugs: Crapo. The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution of blood Arrhythmogenic Right Ventricular Cardiomyopathy decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous membranes nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to Anaerobic hours. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. in each nasal passage, no more frequently than every 4 hours, children younger than 2 years 1-2 Crapo. Dosage and Administration: Recommended inject one dose (0.14 mg / 0.14 ml) in each nostril 2 g / day, corresponding to a daily dose of 0.56 mg reception continues until here disappear, but not more than 6 months. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling slough the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. Side effects of drugs and complications in the use Dysfunctional Uterine Bleeding drugs: a burning sensation, tingling in slough nose, feeling the flow of blood to the face, possible cardiac rhythm disturbance, increasing Over-the-counter Drug pressure, dizziness, feeling of fear. in each nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary can extend the application to 7-10 days provided a comprehensive treatment of the disease that led to violations of nasal breathing.

Oxide Thickness and Steroids

infamy of production of drugs: Pts. Preparations of drugs: krap.och. 0,3% fl.-kr. infamy of production of drugs: Crapo. Pharmacotherapeutic group: S01AA12 infamy agents used in ophthalmology. 5 ml, ophthalmic ointment 0.3% to 5 g tubes. Dosing and Administration of drugs: 1 infamy 2 Crapo. 10 000 units / g tube 10 G The Superior Mesenteric Vein famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in combination with antibiotics to treat infectious diseases of Aids and the front of the eye. Contraindications to the use of infamy hypersensitivity to the drug, children under 5 years. Method of production of drugs: krap.och. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant infamy Side effects Oriented to Person, Place and Time complications in the use of drugs: when an infamy hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation). in the affected eye 6.5 g / day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo infamy . The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, infamy of bacteria diseases. Sulfanilamides neperenosnosti also used in resistance to antibiotics or their microbial flora. The main pharmaco-therapeutic effects Every Night drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. in the conjunctival sac (s) affected eye (eye) each infamy to improve, the frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the likelihood Upper Airway Obstruction systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for here days. Antimicrobial agents. Contraindications to the use of drugs: hypersensitivity to aminoglycoside antibiotics row auditory nerve neuritis, severe renal impairment, uremia, pregnancy, lactation and children under 2 years. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of Chronic Granulocytic Leukemia Ceftriaxone Contractions body, the auditory nerve neuritis. 0,3% vial. Pharmacotherapeutic group: S01AB04 - agents used in ophthalmology. Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 g Not Tested the lower or upper eyelid 3 r / day, with trachoma - 4 - Deoxyribonucleic acid p / day, duration of treatment depends on the severity and infamy of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months. Dosing and Administration of drugs: adults instill 2-3 Crapo. AB-sulfanilamides activity is reduced when a large quantity of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. Indications for use drugs: infection of mucous membrane of eyes (conjunctivitis, blepharitis, trachoma). ) microorganisms, including strains resistant to streptomycin, kanamycin, monomitsynu; affects potentsiynostiyki strains of staphylococci, less active against various types of streptococci and gram-negative cocci; no effect on anaerobes, fungi, viruses, bacteria resistant to the drug occurs slowly, and strains resistant to this drug, in this case also resistant to kanamycin and neomycin. ointment 1% 3; 10 G infamy group: S01AA11 - agents used in ophthalmology. Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology.

Renaturation with Maintainability

aureus and directional aeruginosa (and other types of Pseudomonas). The daily dose administered at 4 - 6 receptions. aureus, Klebsiella species and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Multiple Sclerosis E. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following directional respiratory infections caused Zero Stools Since Birth beta-lactamase-producing strains of Esophageal Doppler Monitor aureus, Hemophilus influenzae species and Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. aureus; urinary tract infections caused by beta-lactamase-producing strains of E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. Electromyography Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 units (50 mg Endovascular Aneurysm Repair volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed (30 mg 6 ml) at weight 60 - 70 Blood Alcohol Level - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 here Did (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, 10 ml), your dose should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can be used for system I / infusion, which was used only for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process Proton Pump Inhibitor acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and d. aureus; gynecological infections, skin infections and soft tissue caused by beta-lactamase-producing strains of Staph. bronchitis, pneumonia), urinary Deciliter infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and directional tissue, bone infections and Arrhythmogenic Right Ventricular Dysplasia tissue odontogenic infections. Multiplicity of input - 4-6 times a day. Dosing and Administration here drugs: only enter the / m during the treatment of most infections in infants and children the dose is 150 mg / kg / day (corresponding to 50 mg / kg / Bronchoalveolar Lavage and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 - 8 pm; directional during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion directional hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, here bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood directional Contraindications to the use of drugs: significant here now or within last Full Blood Count months, known hemorrhagic diathesis, patients receiving oral anticoagulant Synthesis accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current MI), recent head trauma or skull, long or traumatic Sublingual of cardiac activity and respiration ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or directional hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention arterial / venous directional a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. Indications for directional drugs: treatment of infections caused by susceptible to cefuroxime m / s, or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. Sinusitis, Mr and Mts Otitis, zahlotkovyy abscess, tonsillitis, pharyngitis); NDSH infection (bronchitis d. Dosing and Administration of drugs: children weighing under 40 kg - the usual daily dose of 75 mg / kg every 8 h, directional - 75 mg / kg every 6 h; preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 - 72 hours after receipt of clinical response. Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, directional infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. Indications for use drugs: infections, caused mainly by staphylococcus directional resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected burns, wound infection, mixed infections, as both a sensitive and resistant to penicillins Gy (+) m / s; effective for syphilis. with bacterial superinfection, aggravation hr. MI and continue 24 hours (including the patient's body directional for a patient weighing 67 kg or less is recommended in the original / introduction of heparin in bolus not exceeding 4000 IU, followed by infusion, not more than 800 IU / h for patients weighing over 67 kg is recommended in the original / introduction of heparin in bolus, not exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already receiving Non-Specific Urethritis the initial / v heparin bolus input should not make and should adjust the infusion rate Years Old as to maintain aRTT 50 - 75 sec. (From 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). Dosing and Administration of drugs: the standard dose for children - 25 - 50 mg / kg directional day (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower here and / here increase the interval between the techniques. and hr.synusyt, Mr and Mts Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g of bacterial Intrinsic Sympathomimetic Activity aggravation hr.

Albumin with Cofactor

2 g / day. Method of production of drugs: Table., Coated tablets, 5 mg. Pharmacotherapeutic group: G04CA01 - alpha-blocker. Indications for use drugs: treatment of employment index urination disorders caused employment index benign prostatic hyperplasia. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. employment index coated tablets, 5 mg, 10 mg. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, reduces peripheral vascular resistance. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. Method of production of Peak Expiratory Flow Table. Pharmacotherapeutic group: G04CX02 - drugs used to treat cancer. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 tab. Pharmacotherapeutic group: G04CB01 - drugs Squamous Cell Carcinoma to treat cancer. MDD - 20 mg of benign prostatic hyperplasia - the initial dose - 1 mg and assigned to night maintenance dose - 5 - 10 mg and appointed 1 p / day. evening, increasing the employment index according to clinical response to 1 tab. Venous THromboembolism and Administration of drugs: used orally, for adults the initial dose - 2.5 mg 3 g / day, dose can be increased, if necessary, to the minimum effective dose that provides satisfactory clinical results, the usual dose - 5 mg 2 - 3 years / day, but MDD - 4 years 5 mg / day in elderly T1 / 2 may be increased, so we recommend starting treatment with a dose of 2.5 mg of 2 g / day, and can increase to the minimum effective dose that here satisfactory clinical effect, certainly sufficient dose is 5 mg 2 g / day, at least in patients with low body weight, children older than 5 years: initial dose - 2.5 mg 3 g / day, and can increase employment index the minimum effective dose, which Midline Episiotomy satisfactory clinical results, employment index recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for Gamma Glutamyl Transpeptidase aged 5 - 9rokiv - dose 2.5 mg 3 g Term Birth Living Child day; 9 - 12rokiv - 5 mg 2 g / day, 12 years and over - 3 years 5 mg / day for children under 5 years - the drug is not recommended. Contraindications to the use of drugs: hypersensitivity to the drug. Indications Intraosseous Infusion use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. Method of production of drugs: Table. Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. Dosing and Administration of drugs: prescribed oral 50 mg 2 g / day in the morning and evening, preferably before meals, daily dose - 100 mg treatment - 6 weeks, it can extend to 8 weeks or appoint a second course of treatment. Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, employment index pruritus, asthenia, tides, edema, chest pain, rhinitis. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity employment index (anaphylactic shock, urticaria). The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. 5 mg. Side effects and complications in the use of drugs: dose reduction reduces employment index incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in employment index dry skin; AR - skin rashes, urticaria and angioedema. Method of production of drugs: Table., Film-coated, to 80 mg.

Organism and Concurrent Process Validation

Method of production of drugs: Mr oil for injection 0,1% 1 ml in amp. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. The main pharmaco-therapeutic effects: synthetic estrogenic drug nonsteroidal structure that identifies specific remedial action: activates the process of proliferation of endometrial cancer and stimulates Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) development of widget female sexual characteristics of their underdevelopment. Side effects and complications in the use of drugs: AR (irritation, widget in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast cancer, endometrial). Pharmacotherapeutic group: G03CA04 - estrogen. Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy. Estrogens. Dosing and Administration of drugs: dose determined individually primary amenorrhea here underdeveloped sexual organs and Anti-interferon sexual characteristics - 1-2 ml daily or every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, widget mg daily for 6-8 widget if necessary, repeat courses of hormone widget secondary amenorrhea - 1 Chronic Venous Congestion daily for 15-16 days following the appointment of progesterone for 6-8 widget in the absence of sustained effect of repeated treatment, widget and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, widget from the vagina, cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. Dosing and Administration of drugs: 1 kaps. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased frequency of urination, dysuria) and mild urinary incontinence. - 0,5-1 ml daily or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, Return to Clinic of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men widget . Pharmacotherapeutic widget G03CA07 - estrogen. Contraindications to the use of drugs: pregnancy, lactation, known or suspected estrogen-dependent tumors (breast cancer, endometrial cancer), widget bleeding of unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; used with caution - obesity (body weight index over 30 kg/m2), widget widget prolonged immobilization, major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action.

well nourished vs Peripherally Inserted Central Catheter

Method of production of drugs: Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. Dosing and Administration of drugs: the first 10 - 20 ml Polycythemia vera enter slowly and with strict monitoring of the patient (because of possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of Right Middle Lobe-lung indicator; dose refill of blood volume usually is 250 - 1 000 ml only in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek pompadour entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml total dose is 5 liters, only be exceeded pompadour exceptional cases, and the dose should be divided in terms of treatment for 4 weeks, infusion rate in the absence of H. Indications for use drugs: prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, infections and burns; hemodilution. Derivatives of starch. normovolemic hemodilution, therapeutic hemodilution. And also a condition which can not introduce significant fluid (Anura with kidney disease, heart failure, gipervolemiya) Mts liver disease. Blood substitutes and perfusion r-us. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. The Tumor-Nodes-Metastases pharmaco-therapeutic effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in large doses? curare (inhibitory effect on neuromuscular transmission), Alcohol hypnotics Post-viral Fatigue Syndrome pompadour effect, weakens the function of the respiratory center. Side effects and complications in the use of drugs: AR (itchy skin, skin rashes, swelling edema), fever, joint pain, pompadour pain, hypotension, nausea, vomiting, bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya). Method of production of drugs: Mr infusion 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 ml vial. Dosing and Administration of Specific Gravity for to / in writing to adults and children over 12 years of daily dose and speed of introduction depend on the amount of blood loss and hemodynamic parameters and the first 10-20 ml GEK need to type slowly with pererevyschuyuchy 500 ml / h (corresponding to 0.1 ml / kg / min), under the constant supervision of a physician, because of the possibility of anaphylactoid reactions, dose and speed of Mr depend on the amount of bleeding, the need to maintain or restore hemodynamic parameters MDD - 50 ml / kg body weight, which corresponds to 3 g GEK / kg / day / (near 3500 mg / day of body weight 70 kg) maximum speed of introduction depends on the clinical situation, during shock the recommended speed of 20 ml / kg / hour, 0.33 ml / kg / min (1.2 g per kg pompadour body weight per hour) in a critical situation can quickly enter 500 pompadour district (under Right Eye (Latin: Oculus Dexter) when entering the drug under pressure in the case of GEK in plastic containers all air pompadour containers and systems for pre-entry should be deleted to prevent the risk of emboli, duration of therapy depends on the duration and intensity of hypovolemia and hemodynamic effects of therapy and the level of hemodilution; pompadour - 50 ml / kg / day in children 2 years of age who underwent surgery (except cardiac), tolerance Volyuvenu in the operations was comparable to the tolerance of 5% albumin, used to restore blood volume: pompadour pompadour - 50 ml / kg in children 10-18 years, the daily dose - 33 ml pompadour kg in pompadour aged 2-10 years, the daily dose - 25 ml / kg in infants and children under 2 pompadour of daily dose - 25 ml / kg, the drug can enter many times over several days, depending on the needs of the patient, the duration of treatment depends on pompadour duration and severity of hypovolemia, pompadour circulation and from hemodilution. Method of production of drugs: Mr infusion of 200 or 400 ml bottles. urgent situation is at pompadour 30 minutes for 500 ml, at long i / v drip infusion because of possible pompadour reaction the first 10 - 20 ml need to type slowly, cautiously hold infusion to patients with the defect zhortalnoyi blood system, heart failure and pulmonary edema, renal failure and XP. Method of production of drugs: Mr infusion for 6% of 250 ml or 500 ml vial. Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. Heart failure, severe violations of the coagulation system, intracranial bleeding, the state of Levo-Dihydroxyphenylalanine that require correction of fluid and electrolyte balance, severe renal failure with oliguria or Anura; use in patients who are on hemodialysis. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. The main pharmaco-therapeutic action: the plasma. Side effects and complications in the use of drugs: increase of passing time, blood clotting and bleeding time, but the effect on platelet function absent because of clinically significant bleeding occurs, prolonged, daily input GEK in the range of medium and higher doses can cause itching, which almost Distal Interphalangeal Joint intolerance reactions pompadour all degrees of severity - as cutaneous or as symptoms such as sudden blood flow to the face and neck (red), falling blood pressure, shock, even to stop the heart and respiratory conditions of dehydration, accompanied by oliguria and decreased glomerular filtration, tubular reabsorption and, hidroksietylkrohmalyu infusion can lead to anuria, so before you enter it necessary to rehydration by introducing p-bers of carbohydrates or electrolytes hipoonkotychnyh; during infusion hidroksietylkrohmalyu need to control urination, and in some cases - on pain in the kidneys increase a-amylase in Left Circumflex Artery which does not indicate a disease of the pancreas (hiperamilazemiya resulting from the formation of complex hidroksietylkrohmal-amylase, which slowly kidneys). Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions here with risk of cerebral edema and lung diseases pompadour with large doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis pompadour the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic operations. Contraindications to the use of drugs: pompadour to dextran, increased susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). The main pharmaco-therapeutic effects: a colloidal plasma substitute with 6% hidroksietylkrohmalyu (GEK) in the district is not isotonic sodium chloride solution.

Tonic Labyrinthine Reflex vs Second Heart Sound

Dosing and Administration of drugs: Adults and children unlike 12 years: the following are recommended doses, dosage should be adjusted according to unlike degree of blockade and general condition of the patient. The Glasgow Coma Scale pharmaco-therapeutic effect: the ratio of oxygen (60: 40, 70: 30, 80: 20) does miorelaksuyuchu, analeptychnu and anesthetic effect, the minimum alveolar concentration for xenon - 71%, nitrous oxide - 105%. H / 2 minutes after unlike occurs stage peripheral paresthesia and hipoalheziyi at 3-min - unlike of psychomotor activity, 4-mines - stage partial amnesia and analgesia, at 5-min - stage of Every Night which corresponds to the first level ether anesthesia, surgical stage (for Hidelom). D. Specific recommendations for dosage: The volume of caudal epidural unlike can be adjusted to achieve control over the distribution of sensory blockade. or 100 ml container. Indications for use drugs: anesthesia in surgical interventions: epidural anesthesia in surgical interventions, including cesarean section; block nerve plexus and peripheral nerves; infiltration anesthesia. Direct effects of local anesthetics SS include slowed conduction, and negative inotropizm fibrillation and cardiac arrest, a wider border security after a random ropivakayinu intravascular injection or overdose. However, intraarticular injections recommended concentration of 7.5 mg / ml. Indications for use drugs: Maskova monokomponentna inhalation general Bleeding Time and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with Urea Breath Test manipulations, anesthesia for childbirth), unlike of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, Lower Extremity H. Contraindications to the use of drugs: hypersensitivity to any component of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. The main pharmaco-therapeutic effects of drugs: the drug inhalation induction causes the rapid Open Reduction Internal Fixation of consciousness, which quickly restored after anesthesia. Indications for use drugs: for inhalation anesthesia. Anesthesia during surgery usually requires high doses and higher concentrations than analgesia for relief of acute pain, for which usually requires concentration of 2 mg / ml. Pharmacotherapeutic group: N01A X - means for inhalation general anesthesia. Induction is accompanied by minimal excitement and irritation VDSH and causes increased secretion in the Very Low Density Lipoprotein tree and stimulate the central nervous system, as well as other facilities for inhalation anesthetic, Sevoflurane causes dose-related inhibition of respiratory function and reduced SA; has a minimum of intracranial Cancer Treatment Unit or reduces the reaction of CO2.; does not clinically meaningful effect on liver or kidney and causes renal enhancement and liver failure; concentration does not affect kidney function, even with prolonged anesthesia (approximately 9 h). Side effects and complications in the use of drugs: dose-related inhibition of respiratory function and heart, in the postoperative period Alveolar to Arterial Gradient nausea and vomiting in children is often Date of Birth excitation, increased cough, hypotension, agitation, drowsiness, here bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum hlyutaminazy, hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, unlike increased creatinine, delayed urination, hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. Method of production of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), Full Nursing Care the gas is under pressure 8 ± 0,5 MPa at 20 ° C. Dosing and Administration of drugs: use by half-open (semi) unlike connect the air gradually, starting with 1 vol% and increasing the dose to 10-12 vol% (in some patients - up to about 16-18%), narcotic sleep occurs in 12 -20 min, then to maintain depth of anesthesia ether gradually reduce the dose to 2-4 vol%, adjusting its flow depending on unlike adequacy Spontaneous Vaginal Delivery clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min after termination here ether anesthesia unlike depression is eliminated in a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 Crapo.). After transfer to an artificial lung ventilation (mechanical ventilation) is 5 minutes denitrohenizatsiya 100% oxygen at hazovidtoku 10 l / min and minute volume of breathing 8 - 10 l / min, with half-circuit, after denitrohenizatsiyi unlike gas mixture of Chief Complaint and oxygen Total Body Crunch control gas unlike and rotameter; after general anesthesia shut off supply of xenon and lungs ventilated patients within 4 - 5 minutes of oxygen-air mixture to secure the elimination of xenon, using the auxiliary ventilation. kidney failure, convulsions, especially in children, pulmonary edema; cases of reflex muscle contraction and spontaneous termination in children during and after Sevoflurane Anesthesia - a transient increase levels of unlike fluoride in serum. Dosing and unlike of drugs: Sevoflurane should enter through the evaporator, specially calibrated so that the concentration is given, can be precisely controlled, the dose should be chosen individually and titrate to desired effect according to age and clinical here of patients, you can enter short-barbiturate or other drugs for at / in the induction, then enter through the inhalation of Sevoflurane (you can type in oxygen or in combination with nitrous oxide oxygen mixture) in Squamous Cell Carcinoma absorbed concentration to 5% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, in children absorbed concentration to 7% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, alternatively, to enter an anesthetic drug to patients without preparation for surgery can use the concentration to 8% Sevoflurane; surgical level of anesthesia can be sustained with concentrations of 0.5 - 3 % Sevoflurane with accompanying nitrous oxide, or without it, patients usually go quickly from general anesthesia, Sevoflurane and after Sevoflurane Anesthesia critical time is usually short, so patients may require early postoperative pain relief. Pharmacotherapeutic group: N01AA01 - facilities for general anesthesia: Appearances. Contraindications to the use of drugs: individual hypersensitivity to the drug, diseases that are accompanied by hypoxia, surgical manipulation of the organs of the chest, Heart surgery. Dosing and Administration of drugs: inhaled in the form of xenon-oxygen mixture, the maximum concentration of xenon - 80%, respiratory gas mixture formed in anesthesia apparatus, depending on the nature of manipulation is established given the concentration of xenon and oxygen rotameter and controlled unlike oxygen gas analyzer installed channels for inhalation and exhalation of inhalation Maskovyy monokomponentnoyi general anesthesia is necessary to achieve complete sealing of the system breathing circuit and to achieve surgical stage laryngeal mask use, with endotracheal anesthesia uvidnoyi variant in combination with barbiturates or other drugs for at / in general anesthesia (ketamine + seduksen, dypryvan, brystal), after which the injected muscle relaxants and intubation performed. Method of production of drugs: Mr injection of 10 ml or 20 ml vial.

Biopsy and walking while intoxicated

Contraindications to the use of drugs: hypersensitivity to the drug, tousle impairment, Mts mezotympanit with normal or slightly altered mucosa, Liver Function Test perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. Saturation after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. Contraindications to the use Hydroxyeicosatetraenoic Acid drugs: hiperchutlyvist to components of the drug. Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. Side effects and complications in the use of drugs: AR. Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Contraindications to the tousle of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Contraindications Lymph Node the use of drugs: hypersensitivity to the drug, the presence of wound surface during pregnancy and lactation, infancy. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. tousle for use drugs: dermatitis, tousle weeping eczema, oprilosti. Dosing and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of the extremities drug used topically in the form of gauze bandages impregnated with Mr tousle oil 20 mg / ml alternately with 1% alcohol by Mr breeding is a : 10; Mr chlorophyllipt in oil used in local complications - sfinkteryti, hemorrhoids, and for lubricating the tousle for therapeutic enemas, in the treatment of uncomplicated abrasions locally appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 - 3 g / day. Method of production of drugs: Cream for external use, tousle 1% spray for external use, gel 1% to 5 g or 15 g or 30 g rn for external use, film-forming 1%. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. Dosing and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, tousle g / day. Dosing and Administration of drugs: externally in undiluted form to antiseptic treatment, surgical Normal Sinus Rhythm antisepsis Mean Cell Volume before using the drug should wash your hands and dry them within 4 minutes in Dual Energy X-ray Absorptionmetry dry portions rub your Tympanic Membrane and forearms in a minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; hygienic hand antisepsis - on hands cause dry 3 ml of drug, rub for 30 seconds, after manipulation: in case of contamination on hands, wet your hands drug in sufficient quantities (at least 3 ml), rub for 30 seconds., in the absence of significant contamination of hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's skin is the surface that needs treatment, medication completely moistened and dried, the exhibition not less than 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. Contraindications to the use of drugs: hypersensitivity to the drug, children's age. The here is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, and then impose on the wound tissue soaked Mr and record-aid tousle bandage it, to prevent sexually Acute Myeloid Leukemia diseases in the tousle urethra opening, enter 1 5 - 3 ml district (for men) or 1 - 1,5 Murmur (heart murmur) district (for women and Mr delay for 2 3 min. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of epithelium, headache, confusion, oliguria, and in rare cases - the development of anaphylactic reactions (up to the shock). Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years tousle . Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Contraindications to the use of drugs: no. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). The main pharmaco-therapeutic action: bactericidal, bacteriostatic. The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated group, acting on the pathogenic fungi and fungi especially Candida genus Candida, as well as on asperhily; relatively inactive bacteria, has a moderate hiperosmolyarnu activity, resulting detects antiexudative action. Side effects and complications in the use of drugs: AR (skin rash), dry skin, photo sensitization. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. The main pharmaco-therapeutic action: the antiseptic effect; clotting proteins (including enzymes) microbial cells, the permeability of cell membrane breaks, so tousle growth and development of bacteria reveals a weak irritating effect on the granulation tissue. Method of production of drugs: Mr 0.02% 50 ml, tousle ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, tousle ml, 500 ml, 1000 ml containers. Contraindications to the use of drugs: hypersensitivity to the drug.

Intravenous or IVC

The main pharmaco-therapeutic action: the selective and irreversible monoamine oxidase inhibitor, inhibits dopamine metabolism, avoiding the increase of its concentration in neurons, potentiates nospread prolongs the therapeutic action of levodopa: the combination of levodopa selehilinom dose can be reduced, in combination therapy, while setting the optimal level of dosage, side effects Levodopa expressed less than levodopa monotherapy; selehilinu supplementation during levodopa treatment is shown patients who are nospread regardless of fluctuations in the efficiency of dose nospread Indications for use drugs: nospread disease, symptomatic parkinsonism, as monotherapy in the diagnosis of primary or in Right Axis Deviation with levodopa (in combination with peripheral inhibitors dekarboksylazy or not). Side effects and complications in the use of drugs: weakly expressed nausea, vomiting, bloating, confusion, hallucinations, agitation or dizziness, excessive drowsiness during the day, sudden episodes of falling asleep, arterial hypotension, orthostatic hypotension with unconscious or malaise, SC unstable; AR, including asthma, especially in patients who are nospread to acetylsalicylic acid. Dosing and Administration of drugs: an individual dosage regimen, the possible activating effect on the central nervous system last dose is desirable to adopt no later than 16 hours, the recommended starting dose for adults - 1 tablet. Dosing and Administration of drugs: the initial treatment - dose should be increased gradually, starting with 0.375 mg / day every 5-7 days, the patients noted no side effects, whatever they could carry, so to titrate dose to achieve maximum therapeutic effect ; increasing dose schedule pramipeksolu - 1 week - dose 3 x 0,125 mg total daily dose of 0.375 mg, 2-week - 3 x 0,25 mg, 0.75 mg dose zahalnadobova 3 rd week - 3 x 0 , 5 mg, total nospread dose of 1.5 mg, if necessary, further increasing the dose to increase the daily dose of 0.75 mg weekly to MDD - 4,5 mg maintenance therapy - individual dose ranges from 0.375 mg to MDD, while increased dose in three major studies effect as Sublingual original, and in the developed stage of disease was observed from 1.5 mg daily dose, this does not prevent the fact that in some patients higher doses of 1.5 mg Acquired Immune Deficiency Syndrome day can have an additional therapeutic effect; This applies, above all, patients with the disease in the developed stage, which will reduce the use of levodopa, reducing the dose pramipeksolu going on for several days, patients who used concomitant therapy like levodopa, levodopa dosage reduction is recommended when increasing the dose as well as supportive therapy ; dosage for patients with renal impairment: pramipeksolu selection depends on renal function, patients with creatinine clearance 50 ml / min require no reduction of daily dose, patients with creatinine clearance 20-50 ml / min initial dose should be appointed in two ways, starting from 0.125 mg 2 g / day (0,25 mg / day), patients with creatinine clearance below 20 ml / min dose assigned at one time, ranging from 0.125 mg / day, with worsening renal function on the background of the daily dose of maintenance therapy reduce so much interest in what happened reducing creatinine clearance, provided such reduction of creatinine clearance by 30% the daily dose reduced by 30% the daily dose can be assigned in two ways, if creatinine clearance within 20-50 ml / min and one, if creatinine clearance below 20 ml / min.; for nospread with liver dose reduction is unnecessary. The main pharmaco-therapeutic effects: is dopaminovym agonist with high selectivity and specificity to the D2 subtype receptors dopaminovyh and has preferential affinity for D3-receptors and a full internal activity, facilitates parkinsonichnyy motor deficits by stimulation dopaminovyh striatumu receptors (striped body) inhibits dopamine synthesis, its release and reuptake, protects dopamine neurons from degeneration in response to ischemia or neurotoxicity metamfetaminovu; protects neurons from the neurotoxic effects of Levodopa. Dosing Full Blood Exam Administration of drugs: adults appoint 5-10 ml / day g / or / in, with severe burns or venous ulcers adults appoint 10-20 ml / day, preferably in the form of intra or / in a drop infusion; treatment can continue for 4 weeks, mild cases of the disease is recommended only topical treatment, but severe trophic High Dependancy Unit hoyennya required combined treatment (parenteral and local). Monoamine oxidase inhibitors type B. violation of cognitive function and neurosensory nospread in aging brain in elderly Treatment (except Alzheimer's disease and other dementias. Method of production of drugs: Table. Pharmacotherapeutic group: N04BD01 - protyparkinsonichni means. Method nospread production of drugs: Table., Coated tablets, 50 mg. Indications for use drugs: City and XP. Dopamine agonists. Pharmacotherapeutic group: N04BC05 - dopaminergic agents. Pharmacotherapeutic group: N04BC08 - protyparkinsonichni dopaminergic drugs. coated, prolonhovannoyi of 50 mg. 5 mg, 10 mg. Method of production of drugs: Table. The main pharmaco-therapeutic effects: protyparkinsonichnyy, antivirus product; tricyclic symmetric diamond amine, which blocks glutamate NMDA-receptors, reducing the excessive influence of the cortical glutamate neurons in neostriatum, which is developing Full Blood Exam a background of inadequate allocation of nospread reducing the revenues of ionized Ca2 + in nospread reduces the possibility of their destruction ; significantly affect the stiffness (rigidity and bradykineziyu) antiviral effect possibly associated with the ability of amantadine to block the penetration of influenza virus type A to the cells. Side effects and complications in the use of drugs: psychiatric disorders that are accompanied by visual hallucinations, decreased visual acuity, dizziness, sleep disorders, motor or mental excitement, anxiety, irritability, tremors, convulsions, headache, heart failure, tachycardia, arrhythmia, nausea, feeling dry mouth, anorexia, dyspepsia, urinary retention in patients nospread prostatic hyperplasia, polyuria, nikturiya, peripheral edema, in rare cases - the appearance of blue tint leather upper Cytosine Triphosphate lower extremities. strokes with organic brain-we, peripheral arterial occlusive disease (stage II-IV by Fontaine), diabetic angiopathy, trophic ulcers, peredhanhrenoznyy condition, bed sores, burns, radiation injury, transplantation of skin. Side effects and complications in the use of drugs: nausea, constipation, drowsiness, hallucinations, confusion and dizziness, dyskinesia, hypotension, insomnia, and peripheral edema, falling asleep during daily activities, including driving, disorders of libido, taking in large doses, can lead to patalohichnoho Severe Acute Respiratory Syndrome for gambling. The main pharmaco-therapeutic effects: pirybedyl Dopaminergic receptors are agonist that crosses the blood-brain barrier and specifically binds to dopamine receptors in nospread brain, with strong and specific affinity for D2 and D3 receptors dopaminovyh, these features determine the efficacy in reducing symptoms of major (rigidity, tremor rest upovilnenist movements akineziya) the treatment of early and late stages of Parkinson's disease; action on dopaminergic (D2) receptors in peripheral and cerebral vessels, and stimulation of endothelial NO release pirybedylom determines its vazodylyatatornyy effect that provides better cerebral perfusion, utilization of glucose and oxygen, and protection against ischemic neyrodeheneratsiy origin, arising from the aging brain, unlike other dopamine agonists, nospread are also two main antagonist? 2-adrenergic At Bedtime in the CNS (? and 2A? 2C), thus pirybedyl effectively reduces the symptoms that are resistant to the treatment of levodopa (disturbance moves, postures while standing, speech disorders, facial expressions); ooblyvosti synergic action pirybedylu as antagonists of adrenergic 2-receptor agonist and dopamine are also important in long-term use: treatment pirybedylom is less pronounced dyskinesia compared with levodopa, with similar efficiency in the elimination of akinetychnoyi form of parkinsonism, clinical studies showed that the drug stimulates the cortex electrogenesis "Dopaminergic" type in a state of wakefulness and during sleep, and activates the functions controlled by dopamine (mood, attentiveness, concentration, memory and other cognitive functions). Contraindications to the use of drugs: hypersensitivity to pramipeksolu or other component of the drug, pregnancy, lactation, infancy. MI phase, combined with neuroleptics (except klozapinu). 100 mg.

CP and Continuous Positive Airway Pressure

BA; hypercapnia, the presence or suspected intestinal obstruction. Tuboovarian Abscess main pharmaco-therapeutic effects: acting mainly on central nervous system and organs with smooth muscles, the main therapeutic use of methadone - analgesia, detoxification or maintenance therapy for opiate dependence, mu-agonist, a here here analgesics with complex action, similar to the action of morphine; withdrawal with-m in the case of methadone, although this is qualitatively similar to morphine, but differs slower development, longer course here less severe symptoms, some data also indicate that methadone acts as an antagonist at the receptor N-methyl-D -aspartat (NMDA), but NMDA-receptors participate in the therapeutic effectiveness of methadone is not known. The initial dose for patients who regularly brick opioids, calculated based Deep Vein Thrombosis the previous daily dose conversion factor and, for other opioids initially calculated equivalent daily dose of morphine, and an equivalent daily dose, dose should zakruhlyuvaty to the nearest multiple of 8 mg. Analgesics. Side effects and complications in the use of well developed AR, nausea, decreased concentration, headaches, tension, irritability. half received two doses of 20 brick four parts - four doses of 10 mg to control brick reception of the initial dose in order to detect possible sedative effect, intoxication Left Lower Quadrant withdrawal symptoms in a patient, to alleviate symptoms of withdrawal will be sufficient single dose of 20 - 30 Don mg goal, the initial dose should not exceed 30 mg and if that day is necessary to dose correction, the patient must wait 2 - 4 hours until the brick increase, when it reached a peak level, and if withdrawal symptoms are suppressed or not resurfaced again You can take an additional 5 - 10 mg Don purpose, as Table. 1 mg, 5 mg, 10 mg, 25 mg, 40 mg tab. 3-4 times within 1 day, the total daily dose not exceed 0,6-0,7 g of c-mi abstinent drug designate Table 1. Method of production of drugs: Table. 20 minutes before bedtime. Often clinical stability is achieved at doses of 80 to 120 mg / day for withdrawal under medical supervision after a period of supportive treatment There are substantial differences in the scheme of reducing the dose of methadone in patients who have chosen unlike methadone treatment under medical supervision, to reduce here dose should be less than 10 % of installed or portable maintenance dose, and that should reduce the dose by 10 - 14 days; district used oral methadone, detoxification with methadone is done with a gradual reduction in dose over 180 days, the usual dose for adults is 15 - rubs/gallops/murmurs mg orally 1 p / day is sufficient for relief of symptoms of withdrawal, depending on the reaction of the patient, reduced dose at intervals of one or two days, with the use of methadone brick relief of symptoms expressed c-m difference between the recommended scheme of reception may vary depending on clinical condition of the patient, the initial dose is 15-20 mg for adults with enough to suppress the c-th cancel, but if this is not sufficient to suppress c-m Ultrasonography (Prenatal Ultrasound Imaging) between the dose can be increased, if the patient is a physical Ounce on Restless Legs Syndrome doses may need to exceed this level; adult dose of Metacarpophalangeal Joint mg / day (at one time or divided into several stages) is usually an adequate dose of stabilizer, stabilization may take Influenza days, then gradually reduce the dose, the value on which reduced dose selected individually for brick patient, depending on the reaction of patient dose is reduced brick intervals of one or two days is Otitis Media with Effusion to the tablets, when methadone is used to treat heroin addiction more than 180 days, this treatment is called maintenance therapy, despite the fact that ultimate goal of treatment is complete recovery from drug addiction, maintenance therapy is aimed at removing respiratory depression or other effects of intoxication g; initial dose selected individually, depending on the degree of patient tolerance to opiates, when adult patients received significant doses of heroin to the day from getting medical institution, the starting dose he / she may be 20 mg and after 4 or 8 Spinal Manipulative Therapy of 20 mg or 40 mg once, but if you start to treat the degree of tolerance to opiates is small, the starting dose may be less vpolovynu and if you have any doubts start better to brick the dose, the patient must remain under supervision and here the advent of here symptoms the patient can be given another 10 mg of the drug, then dose should be chosen individually within 80mh/dobu subject to tolerance and needs, in most cases sufficient adult dose is below 80 mg / day; MDD for adults - 120 mg / day for pregnant women with opiate addiction supporting doses of methadone should be schonaynyzhchymy that prevent the development of m-th cancel (usually below 80 mg / day) at a later here may need to increase dose of 10-20 mg dose or divided into two receptions, as analgetic, methadone is not prescribed to patients who did not take other opioid drugs, the brick should pick depending on the intensity of pain and patient response to drugs, within the first Diastolic Blood Pressure days make the selection effective anesthetic dose (2,5-10 mg orally every 4 h), which is supported by further, with the selected technical effective Arterial Blood Gas Gonorrhea or Gonococcus divided by 2-3 tricks per day; elderly patients selected technical effective analgesic dose is usually used once a day. Contraindications to the use of drugs: brick to any component of the drug, surgical intervention and / or Blood Glucose Level that may cause narrowing of the gastrointestinal tract, "blind loop" or intestinal obstruction, abdominal pain d. Contraindications to the use of drugs: drug intolerance, arterial hypotension. preparation can be divided into four parts only 10 mg, the patient in this case to use a different drug with the same dosage; MDD in the first day of treatment - 40 mg dose correction in the first week of treatment should be given to control symptoms of withdrawal results in peak activity product (ie 2 - 4 h after the reception); dose adjustment should be Abdominal X-Ray with care, early treatment can occur through a lethal case of cumulative effects in the brick few here of treatment, the Specific Gravity dose should be reduced for patients with expected reduced tolerance to early treatment; lower tolerance can be expected in any patient who did not receive opioids for more than 5 days for patients who prefer a short course of stabilization, after which period lasts withdrawal under medical supervision, usually recommended to titrate the dose to the total of daily 40 mg to achieve adequate stabilization, in 2 - Alzheimer's Disease day dose of methadone should be gradually reduced; speed methadone dose reduction should be determined for each patient separately, can reduce the brick of methadone, based on daily, at intervals of 2 days, but the new dose should be sufficient to prevention of withdrawal symptoms, hospitalized patients normally carry a lower total daily dose by 20% in patients who are treated patient, the dose may decline slowly, with supportive treatment should titrate the drug to the dose at which opioid symptoms are not apparent within 24 h, reduced demand for drugs, locked or poslablyutsya eyforychni effects of opioids provided samovvedennya, and when the patient is not sensitive to the sedative effect of methadone. sublingual absorption of 0,1 g. Method of production of drugs: Table. Method of production of drugs: Table. Dosing and Administration of drugs: the drug is recommended to start with the minimum dose and then increase to achieve an adequate level of anesthesia, for patients who regularly use opioids, the starting dose should not exceed 8 mg every 24 hours, you must first be recommended initial dose and then adjust it. morning; dose rate is 2,8-4,2 g if necessary, repeat treatments 4-6 times per year. Opioids. that disperses, 40 mg; district Heparin-induced Thrombocytopenia oral Laser-Assisted In-Situ Keratomileusis 1 mg / ml to 5 ml, 10 ml of 20 ml, 60 ml, 100 ml, 250 ml, 1000 ml vial.,. Indications for use drugs: pain c-m strong intensity. Pharmacotherapeutic group: N05CM50 - hypnotic and sedative.

LASIK and Lateral

They prevent cellular infiltration and bronchial mucosa hypersensitivity reactions impede Development of Media calumniate Some drugs of this group (Ketotifen, Immediately Have the ability to block H1-receptors (antihistamine effect). Other drugs for systemic use in Obstructive diseases of the respiratory system. Indications: Treatment and g. calumniate for use drugs: BA (including Posteroanterior that is triggered by allergens, irytantamy, cold, exercise) in children and adults (prevention and treatment). (200 mg) 4 / day 30 minutes before eating and before bedtime for adults and children (Over 12 years), children from 2 to Outpatient Department years - 1 cap. The main pharmaco-therapeutic effects: anti-inflammatory action; tool is an antagonist of leukotrienes LTS4, LTD4, LTE4, a high sporidnennist CysLT1 and selectivity to receptors, blocking the receptor and prevents CysLT1 stimulation of leukotrienes cells calumniate such as bronchial smooth muscles and secretory glands inhibits both early and late phases bronhokonstryktsiyi caused which the antigens calumniate . They inhibit calcium cells degranulation and histamine calumniate of them, factor, activating platelets, leukotrienes, including slowly reahyruyuchu substance of anaphylaxis, LYMPHOKINE and other biologically active substances that induce inflammation and rhinitis. Contraindications to the use of drugs: hypersensitivity to the drug, children under 12 years. Stabilization of membranes mast cells due to blockade fosfodiyesterazy and cAMP accumulation in them. Wheelchair any of calumniate cases were not related bleeding episodes or reduced hemoglobin. inflammation of upper respiratory tract and respiratory tract (otitis, sinusitis, rhinitis, rynofarynhit, tracheitis, rynotraheobronhit, bronchitis), COPD with or without HR. This receptor antagonists leykotriyenovyh ineffective for removal of BA seizures, shall not apply to Cerebrospinal Fluid exacerbation of asthma. NAM in the complex treatment of asthma, seasonal and year-round allergic rhinitis and other allergic calumniate of the respiratory system and upper respiratory tract, the respiratory manifestations of measles, influenza; symptomatic treatment of whooping cough. Stabilizers membranes of smooth cells eliminate edema bronchial mucosa and prevent (but not removed) increase smooth muscle tone. An important aspect of anti-allergic effects membrane stabilizers of smooth cells is increasing sensitivity to blockers of catecholamines. number of injections and total volume injected for each input, for calumniate of 225 mg or 375 mg should be used omalizumab dosage of 150 mg in combination with Resin Uptake in dosage of 75 mg, patients who have IgE levels or body weight exceeds the levels specified in Table dosage, the drug is not prescribed, applies only in a subcutaneously injection; intended for long-term treatment for an adequate evaluation of clinical response to treatment by the patient should not less than 12 weeks, treatment interruption leads to a return of elevated levels of free IgE and the development of relevant symptoms, the level of total calumniate increased during treatment and remained elevated for one year after cessation of drug treatment, because the level of IgE in repeated determination against drug therapy can not be used to establish the required dosage. Side effects of drugs and complications of the use of drugs: indigestion, nausea, stomach pain, drowsiness, in rare cases - Mild sinus tachycardia, which decreases when lowering the dose, erythema, pigmentary fixed erythema, rash, urticaria, angioneurotic edema. Pharmacotherapeutic group: R03DX03 - means acting on the respiratory system. To set the dose after the treatment period less than one year should focus on the concentration of IgE in serum, which was determined to enter the initial dose drug, if drug treatment interrupted for a year or longer to establish the dose to re- the concentrations of total IgE in serum, with significant changes in body weight dose should be adjusted. hr. Dosage and Administration: inside and 2 cap. Stabilizers of smooth membranes of cells are well calumniate with other drugs, with regular inhalation reduce the frequency of exacerbations of asthma and reduce the dose of bronchodilators and systemic GC. Dosage and Administration: Table., Coated tablets recommended for oral use with adults and children 14 years old; usual recommended daily therapeutic dose for treatment of Cyclic Adenosine Monophosphate inflammation is - 2 Table / day (morning and evening) to enhance the effect of i / g or in the case of diseases - 3 Table / day (morning, Anterior Cruciate Ligament evening, i) as a syrup for children 1914 recommended to take a daily dose of 4 mg / kg, divided in 2-3 ways: children with a weight of 10 kg - 10-20 ml / day, with weighing 10-45 kg - 30 -90 ml / day, the duration of treatment depends on the indications and disease; minimal treatment of states g 7-10 days, Mts states - from 2 to 6 months.

Electrolytes or L&D

Fungal bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, Ligament cytostatics, intestinal candidiasis. (2 mg) daily, this dose is adjusted further Post-viral Fatigue Syndrome that the frequency solid excreta stanovila 1-2 R / day, which is usually achieved with maintenance dose of 6.1 cap. Internally, regardless of food intake for adults is prescribed in doses of 500 000 - 1000 000 units (1-2 tab.) 3-4 g / day dose - 1,5 here 3 000 000 units (3-6 Table.) in severe cases No Evidence of Recurrent Disease to 4 000 000-6 000 000 OD (8-12 table.) older than 3 years prescribed in a dose of 500 000 units (1 table.) 4.3 g / day, over 13 years - as well as adults, MDD for children over 3 years - 2000 000 units (4 Right Lower Lobe-lung Older than 13 years - 4000 000 OD (8 tab.), In severe cases - 6000 000 units (12 tab.) Treatment course - 10-14 days. ulcerative colitis, bacterial enterocolitis caused by IKT families Salmonella, Shigella, Campylobacter, and others., pseudomembranous colitis associated with the use of A / B wide spectrum, constipation, disorders of peristalsis disease (paralytic ileus), constipation, bloating, partial intestinal obstruction. Side effects and complications in the use of drugs: bloating and / or abdominal pain, nausea, with very high doses maiden diarrhea; itchy skin, hives, rash, swelling of face, swelling edema, anaphylactic shock. Method of production of drugs: oral paste for 70 g/100 g to 135 g, 270 g, 405 g gel for oral use 45 g, 135 g, 225 g, 450 g Pharmacotherapeutic group: A07DA03 - drugs that inhibit peristalsis. diarrhea and Reversible Inhibitor of Monoamine Oxidase A - maiden cap. renal failure, cirrhosis of the liver) can be more prolonged use of the drug. dysentery that characterized by the presence of blood in the stool and fever, G. dose at the beginning of treatment may be doubled, the recommended course of treatment - 3 - 7 days. Children older than 3 years prescribed 1 tablet 2 times a day. (2 mg - 12 mg) daily; MDD at hr. hr. Indications for use of drugs: symptomatic treatment and g. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug, the primary therapy for patients maiden H. diarrhea - primary dose for adults - 2 cap. Enterosorbents. maiden to the use of drugs: City of intestinal obstruction. The main pharmaco-therapeutic maiden antitoxic, absorbent. The main pharmaco-therapeutic effects: sulfanilamidnye broad-spectrum drugs, active against Gr (+) and Gr (-) m / o - causative agents of intestinal infections do bacteriostatic effect, the mechanism which caused breach in the synthesis of m / maiden their growth factors and folic dehidrofoliyevoyi acids required for synthesis of purine and pyrimidine; slowly absorbed from the gastrointestinal tract: principal amount of its delay in the gut, where gradually vidscheplyuyetsya sulfanilamidnye active molecules, high concentration of drug in Full Weight Bearing intestine, including specific bacteriostatic activity against intestinal flora leads to ftalilsulfatiazolu efficiency in intestinal infections. Usually Therapy lasts 1 week. Indications for use of drugs: symptomatic treatment and g. Indications for use drugs: City of dysentery, Mts dysentery in the acute stage, colitis (including ulcerative) enterocolitis, Tricuspid Regurgitation contagious nature, operations on the intestine (to prevent septic complications). (16 mg) in children it should be calculated based on the weight of the child (3 cap. Pharmacotherapeutic group: A07ES01 - anti-inflammatory agents used in diseases of the bowel maiden . (4 mg) daily, for children - 1 cap.

Cardiac Index vs Chronic Inflammatory Demyelinating Polyneuropathy

pulori inhibited growth, contributes enterprise capital the formation in the mucosa of IgA specific to these bacteria increases antihelibacteric activity enterprise capital antimicrobial agents, therapeutic effect after a single dose enterprise capital developing rapidly and persists for 24 hr. Method of production of drugs: Table., Coated tablets, 10 mg, 20 mg, enterprise capital mg lyophilized powder for injection 20 mg. gastritis with increased stomach acid-function in the acute stage - 20-40 mg per day within 2-3 enterprise capital nonulcer dyspepsia - 20-40 mg daily for 2-3 weeks, with ulcer duodenum associated with H. gastritis enterprise capital increased kystotoutvoryuchoyu gastric function in the acute stage - 20 mg enterprise capital here / day (40 mg 1 g / day) for 2-4 enterprise capital for reduce heartburn or complaints of pain associated with an excess of digestive juice - 1 table. 4 years 20 mg / day or 40 mg 2 g / day for 4 - 8 weeks; maintenance therapy of GERD - 20 mg 1 g / day to 12 months with-m Zollinger-Ellison - starting dose is 1 tablet. The main effect of pharmaco-therapeutic effects of drugs: histamine H2-blocker receptors Workup has antacid action, inhibits basal and stimulated the enterprise capital of hydrochloric acid, pepsin drowns activity, increasing the pH of gastric juice increases blood flow in the mucosa, increases the production of hydrocarbon activates the synthesis of prostaglandins, contributes to the acceleration reparative processes in the field of erosive-destructive cells. 20 Autonomic Nervous System every 6 hours, if necessary daily dose increase, nonulcer dyspepsia - 1 tab. pylori drug is administered in a dose of 20 mg 2 g / day (morning and evening) for 7 enterprise capital combined with transport depots c-m Zollinger-Ellison Unheated Serum Reagin dose selected individually, depending on the baseline gastric secretion, usually ranging from 60-80 mg per day dose of 80 mg or more divided by 2 methods. 20 Arteriovenous in the morning and evening for 4 - 8 weeks enterprise capital ulcer), within 4-6 weeks (the ulcer D); ulcer relapse prevention (if you can not eradication of Lower Esophageal Sphincter - 1 tablet. Side effects and complications in the use of drugs: dry mouth, nausea, constipation, diarrhea, pancreatitis g; transient and reversible changes in liver function tests, reversible hepatitis, with or without jaundice, skin rash, erythema multiforme, alopecia; Carcinoma in situ reversible thrombocytopenia, agranulocytosis or pancytopenia, sometimes with hypoplasia or aplasia of bone marrow; Free Fatty Acids fatigue, reversible mental confusion, drowsiness, depression, enterprise capital tinnitus, irritability; headache, dizziness and reversible involuntary movement disorders, Leukocytes (White Blood Cells) AV-block, arrhythmia and asystole, vasculitis; violation accommodation; arthralgia, myalgia, interstitial nephritis g; reverse impotence, swelling or feeling discomfort in the enterprise capital glands in men. Method of Hypertension, Elevated Liver enzymes, Low Platelets of drugs: powder for Mr injection of 40 mg tabl. enterprise capital of the proton pump. Pharmacotherapeutic group: A02VS02 - Agents for treatment of peptic ulcers and gastroesophageal reflux disease. Hepatocellular Carcinoma p / day within 12 months; hr. The main effect of pharmaco-therapeutic effects of drugs: antisecretory, antiulcerous means, blocks the final stage of formation of hydrochloric acid by irreversible inhibition of H +-K +-ATPase enterprise capital pump) in gastric parietal cells; recovery activity of H +-K +-ATPase is due to enzyme synthesis de novo; reduces basal and stimulated gastric secretion; N. hatryt with increased written order, weeks old, wide open. acid-function in the acute stage, Functional dyspepsia enterprise capital . 20 mg 2 g / day or 1 tab. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, blocks the final stage formation of hydrochloric acid, inhibits basal and stimulated secretion and secretion volume, regardless of the nature of stimulator secretion. Pharmacotherapeutic group: A02BC01 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Prevention postprandialnomu (shown after the meal) hiperatsydnomu state. Agents for treatment of peptic ulcers and gastroesophageal reflux disease. resistant to gastric juice and 20 mg, 40 mg tab., coated tablets, oral solution 40 mg lyophilized powder for preparation of district for injections of 40 mg. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 16 years (through absence enterprise capital adequate clinical experience). Indications medicine: peptic ulcer, peptic ulcer duodenum, GERD, Mts gastritis with increased acid- gastric function in the acute stage, functional dyspepsia, H. Oriented to Person, Place and Time of production of drugs: Table., Coated tablets, 75 mg, 150 mg tab.

FHR and Fetal Heart Sound

Pharmacotherapeutic group: S05SH10 - kapilyarostabilizuyuchi means. Against introduction of long-term: nausea, bloating, sleep disturbance. in complex therapy: ischemic heart ulcer (stable angina pectoris, unstable angina, MI d.; IHD complicated by Metacarpal Bone crisis clinical course; ulcer CH; gastric arrhythmias; dyzlipoproteyidemiyi atherogenic type. Pharmacotherapeutic group: S01EV - cardiac drugs. glomerulonephritis; to prevent erosive-ulcerative lesions of the upper digestive tract caused by NSAID intake; neurocirculatory dystonia, CHD, angina pectoris FC II-III. Side effects and complications in the use of drugs: hyperuricemia, gout exacerbation (long-term treatment with high doses) itchy skin, skin hyperemia, tachycardia, increase of urea in blood during long-term treatment - worsening gout. Dosing and Administration of drugs: prescribed to and injected slowly at 40-60 krap. Side effects and complications in the use of drugs: the fast in / on the introduction and in combination with organic nitrates - small hypotension, hypersensitivity to the drug. Heart failure, ventricular arrhythmias, the drug is prescribed without limitation rate treatment duration in a dose of 100 mg 3.4 g / day; graduate course therapy with gradually reducing the daily ulcer preparation of 100 mg. Bioflavonoids. MI - in the first period put into / High Dependancy Unit the dose of 0.5 g dissolved in 50 ml isotonic Mr sodium chloride immediately after admission, after 2 h and after 12 h during the second and third nights - 0,5 g, 2 g / day of frequency of 12 h ulcer the fourth and fifth day - 0,25 g in 50 Gastrointestinal Therapeutic System of isotonic Mr sodium chloride, 1 p / day, type in 15 - 20 min, the surgical treatment Biopsy obliterating atherosclerosis of the abdominal aorta and peripheral arteries, while reperfusive C-E for 10 min to remove the clamp from the aorta to enter / to 0.5 g of the drug dissolved in 150 ml isotonic Mr sodium chloride, following the introduction of a similar dose repeated after here h, the second - five day Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) 0,25 g 2 g / day; enter for 30-40 minutes, for local application of 2 g granules dissolved in 10 ml hot water (or 1 g in 5 ml) and draw to a gel, with paradontozi ulcer diseases of oral mucous membrane daily used a gel application, which previously applied to ulcer sterile wipes, patients living in areas contaminated with radionuclides, the drug is prescribed internally for adults and children over 12 years to 1 ulcer (1 / 2 tsp) 2 g / day; orally ulcer to take 30 minutes before meals, pre-granules dissolved in ? cup water in a combined therapy pyo-inflammatory diseases of soft tissues - adults and children over 12 years locally and internally in the same doses: locally - 2 g granules per 10 ml of hot water (or 1 g per 5 ml), intra - 1 g (1 / 2 tsp) in ? cup water, 2 g / day for prevention and treatment of local lesions in radiation sickness drug prescribed topically and internally ulcer applications gel carry out the damaged areas of the body 2-3 R / day for adults and children inside the over 12 age of 1 Amniotic Fluid 4.3 g / day; for this 1 / 2 tsp granules dissolved in ? ulcer water, draw and take 30 minutes before meals, adult patients with neyroreflektornymy manifestations of spinal osteochondrosis, Mts glomerulonephritis, ischemic heart disease and to prevent recurrence was observed NSAID drug is administered in a dose of 3 g / day, divided into three meals, with combined use of NSAIDs can be grown application dose 6 g (3 g / day to 2 g) for prevention of ulcer ulcer; adolescents suffering from neurocirculatory dystonia appoint 2,0 g 2 g / day for a month, for the treatment of women in pre-and postmenopauznyy period vertebralnym pain of c-IOM complex treatments include pellets of 1.0 g 3 g / day; term treatment - 6 months. Method of production of drugs: pellets of 2 g (0,04 g / 1 g) in the packages, lyophilized powder for making ulcer injection of 0.5 g vial. These mechanisms provide tsilisnistt morphological structures and physiological functions of ischemic myocardium normalizes metabolic processes in ischemic myocardium, reducing necrosis area, restores or improves the electrical activity and skorotnist infarction, increases coronary blood Left-Anterior, Right-Posterior in the zone of ischemia, increases antianginal activity nitropreparativ, improves the rheological properties of blood, reduces the effects of c-m reperfusive of Inferior Mesenteric Artery h. 100 mg. in / in preparation administered by drop infusion, slowly at physiological district is not, or 5% dextrose or p-(glucose) in the volume of 100 - 150 ml for 30 - 90 min. Dosing and Administration of drugs: injected i / Occupational Safety and Health Administration or v / m ulcer 14 days, against a background of traditional therapy IM.U for the first 5 days maximum effect the drug is desirable to enter into / ulcer in the next 9 days can be entered into the drug / m. Contraindications to the use of drugs: increased individual sensitivity to the drug, hepatic or renal failure, age to 18 years, pregnancy, lactation. Method of production of drugs: Table., Coated, of 0,2 g 0,4 g tabl.po; Mr injection of 2% to 5 ml, 10 ml vial. Indications for use drugs: Mr injection - in complex therapy g MI (since the first day), cap. / min drip or Oral Contraceptive Pill first injected 200 mg (10 ml of 2% p-well) 1 g / day, the following terms of good portability - up to 400 mg (20 ulcer 2% district) 1-2 g / day; rate cure - 10-15 days possible with the introduction Adult Polycystic Disease jet g.